International Biotechnology Trust’s Madrigal Pharmaceuticals MDGL Stock Holding History

International Biotechnology Trust’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.67M	Hold	18,300	–	–	0.9%	33
2023 Q2	$4.23M	Buy	+18,300	New	+$4.96M	1.29%	24
2022 Q4	–	Sell	-5,350	Closed	-$348K	–	67
2022 Q3	$348K	Buy	5,350 +4,967	+1,297%	+$345K	0.11%	63
2022 Q2	$5.35K	Sell	383 -4,967	-93%	-$365K	0.06%	76
2022 Q1	$5.07M	Buy	+5,350	New	+$451K	1.14%	29
2018 Q4	–	Sell	-10,000	Closed	-$1.64M	–	48
2018 Q3	$1.64M	Hold	10,000	–	–	0.78%	35
2018 Q2	$2.79M	Buy	+10,000	New	+$1.76M	1.07%	33
2018 Q1	–	Sell	-25,000	Closed	-$2.29M	–	65
2017 Q4	$2.29M	Buy	+25,000	New	+$1.43M	0.81%	36

Other funds holding MDGL

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

International Biotechnology Trust's MDGL Position: Q3 2023 in Review

International Biotechnology Trust held its Madrigal Pharmaceuticals (MDGL) position steady in Q3 2023 at 18,300 shares worth $2.67M. The position accounts for 0.9% of the portfolio, ranked #33.

International Biotechnology Trust first reported a position in MDGL in Q4 2017 and has held it in 8 quarters since. The position peaked at $5.07M in Q1 2022. 205 funds tracked by Wall St. Rank hold MDGL as of Q3 2023.

International Biotechnology Trust held 18,300 shares of Madrigal Pharmaceuticals worth $2.67M as of Q3 2023.
International Biotechnology Trust left its Madrigal Pharmaceuticals share count unchanged in Q3 2023.
Madrigal Pharmaceuticals made up 0.9% of International Biotechnology Trust's portfolio in Q3 2023, its #33 holding.
International Biotechnology Trust first reported a position in Madrigal Pharmaceuticals in Q4 2017 and has held it in 8 quarters since.
International Biotechnology Trust's Madrigal Pharmaceuticals position peaked at $5.07M in Q1 2022.
205 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.